KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Research & Development (2016 - 2025)

Historic Research & Development for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $754.0 million.

  • Medtronic's Research & Development rose 817.79% to $754.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $2.8 billion, marking a year-over-year increase of 349.98%. This contributed to the annual value of $2.7 billion for FY2025, which is 10.97% down from last year.
  • As of Q4 2025, Medtronic's Research & Development stood at $754.0 million, which was up 817.79% from $726.0 million recorded in Q3 2025.
  • Over the past 5 years, Medtronic's Research & Development peaked at $754.0 million during Q4 2025, and registered a low of $601.0 million during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $676.0 million (2021), whereas its average is $681.2 million.
  • Per our database at Business Quant, Medtronic's Research & Development skyrocketed by 2077.29% in 2021 and then tumbled by 773.33% in 2022.
  • Over the past 5 years, Medtronic's Research & Development (Quarter) stood at $676.0 million in 2021, then changed by 0.0% to $676.0 million in 2022, then increased by 3.25% to $698.0 million in 2023, then dropped by 0.14% to $697.0 million in 2024, then rose by 8.18% to $754.0 million in 2025.
  • Its Research & Development was $754.0 million in Q4 2025, compared to $726.0 million in Q3 2025 and $684.0 million in Q2 2025.